Literature DB >> 20884883

Vascular angiotensin-converting enzyme 2: lord of the ring?

Daniel Batlle, Jan Wysocki, Mirza S Khan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20884883      PMCID： PMC2953869          DOI： 10.1161/CIRCRESAHA.110.229831

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  27 in total

1.  The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis.

Authors:  Georg Nickenig; David G Harrison
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

2.  Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.

Authors:  Merlin C Thomas; Raelene J Pickering; Despina Tsorotes; Audrey Koitka; Karen Sheehy; Stella Bernardi; Barbara Toffoli; Thu-Phuc Nguyen-Huu; Geoffrey A Head; Yi Fu; Jaye Chin-Dusting; Mark E Cooper; Chris Tikellis
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

3.  Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.

Authors:  Koichi Yamamoto; Mitsuru Ohishi; Tomohiro Katsuya; Norihisa Ito; Masashi Ikushima; Masaharu Kaibe; Yuji Tatara; Atsushi Shiota; Sumio Sugano; Satoshi Takeda; Hiromi Rakugi; Toshio Ogihara
Journal:  Hypertension       Date:  2006-02-27       Impact factor: 10.190

4.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.

Authors:  M Donoghue; F Hsieh; E Baronas; K Godbout; M Gosselin; N Stagliano; M Donovan; B Woolf; K Robison; R Jeyaseelan; R E Breitbart; S Acton
Journal:  Circ Res       Date:  2000-09-01       Impact factor: 17.367

6.  Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

Authors:  Carlos M Ferrario; Jewell Jessup; Mark C Chappell; David B Averill; K Bridget Brosnihan; E Ann Tallant; Debra I Diz; Patricia E Gallagher
Journal:  Circulation       Date:  2005-05-16       Impact factor: 29.690

7.  Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

Authors:  Minghao Ye; Jan Wysocki; Parveen Naaz; Mohammad Reza Salabat; Michael S LaPointe; Daniel Batlle
Journal:  Hypertension       Date:  2004-04-12       Impact factor: 10.190

8.  Angiotensin-converting enzyme 2 is an essential regulator of heart function.

Authors:  Michael A Crackower; Renu Sarao; Gavin Y Oudit; Chana Yagil; Ivona Kozieradzki; Sam E Scanga; Antonio J Oliveira-dos-Santos; Joan da Costa; Liyong Zhang; York Pei; James Scholey; Carlos M Ferrario; Armen S Manoukian; Mark C Chappell; Peter H Backx; Yoram Yagil; Josef M Penninger
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

Review 9.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 10.  Angiotensin-converting enzyme II in the heart and the kidney.

Authors:  Ursula Danilczyk; Josef M Penninger
Journal:  Circ Res       Date:  2006-03-03       Impact factor: 17.367
View more
  4 in total

1.  ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.

Authors:  Hai-Yan Jin; Bei Song; Gavin Y Oudit; Sandra T Davidge; Hui-Min Yu; Yan-Yan Jiang; Ping-Jin Gao; Ding-Liang Zhu; Guang Ning; Zamaneh Kassiri; Josef M Penninger; Jiu-Chang Zhong
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

2.  The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.

Authors:  Adriana Albini; Giovanni Di Guardo; Douglas McClain Noonan; Michele Lombardo
Journal:  Intern Emerg Med       Date:  2020-05-19       Impact factor: 3.397

3.  Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?

Authors:  Jan Wysocki; Daniel Batlle
Journal:  Nephrol Dial Transplant       Date:  2013-06-19       Impact factor: 5.992

Review 4.  The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease.

Authors:  Li Chen; Guang Hao
Journal:  Cardiovasc Res       Date:  2020-10-01       Impact factor: 10.787
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.